Provided by Tiger Fintech (Singapore) Pte. Ltd.

Maravai LifeSciences Holdings, Inc.

2.01
-0.0350-1.71%
Post-market: 2.010.00000.00%16:20 EDT
Volume:1.28M
Turnover:2.59M
Market Cap:289.36M
PE:-1.91
High:2.12
Open:2.03
Low:1.99
Close:2.05
Loading ...

Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview

Reuters
·
06 Mar

May 05, 2025 Deadline: Contact Levi & Korsinsky LLP to Join Class Action Suit Against MRVI

TIPRANKS
·
06 Mar

Hold Rating on Maravai Lifesciences Due to Filing Delays and Financial Reporting Concerns

TIPRANKS
·
05 Mar

Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
05 Mar

Stifel Nicolaus Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
05 Mar

Maravai LifeSciences Delays 2024 Annual Report Filing

TIPRANKS
·
05 Mar

BRIEF-Maravai Lifesciences Holdings Inc Files For Non-Timely 10-K With The U.S. SEC

Reuters
·
05 Mar

Maravai LifeSciences Holdings: Identified Error in Year-End Financial Close Process With Respect to REV Recognition Associated With Single Shipment

THOMSON REUTERS
·
05 Mar

Maravai LifeSciences Holdings-Needs Additional Time to Complete Goodwill Impairment and Inventory Assessment

THOMSON REUTERS
·
05 Mar

Maravai LifeSciences Holdings Inc -Files for Non- Timely 10-K With the U.S. SEC

THOMSON REUTERS
·
05 Mar

Maravai LifeSciences Holdings-Non-Cash Goodwill Impairment Charge of About $12 Mln Is Expected to Be Recorded for Q4 2024

THOMSON REUTERS
·
05 Mar

Maravai LifeSciences Is Maintained at Buy by B of A Securities

Dow Jones
·
03 Mar

Bank of America Securities Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
03 Mar

Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development

Insider Monkey
·
28 Feb

Baird Downgrades Maravai Lifesciences to Neutral From Outperform, Cuts Price Target to $3 From $9

MT Newswires Live
·
26 Feb

Maravai LifeSciences Cut to Neutral From Outperform by Baird

Dow Jones
·
26 Feb

Maravai Lifesciences downgraded to Neutral from Outperform at Baird

TIPRANKS
·
26 Feb

Maravai LifeSciences Delays Earnings Release Amid Financial Review

TIPRANKS
·
26 Feb

Stock Track | Maravai LifeSciences Plunges 18.70% Pre-Market as Q4 Earnings Postponed Due to Revenue Recognition Issues, Internal Control Weakness

Stock Track
·
25 Feb

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

MT Newswires Live
·
25 Feb